rs10428531

Variant names:

• chr5-36686863-G-A
• rs10428531
• NM_004172.5:c.*594G>A

Your query was ambiguous. Multiple possible variants found:

• chr5-36686863-G-A
• chr5-36686863-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Moderate BP6_Moderate BA1

The NM_004172.5(SLC1A3):​c.*594G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0171 in 164,734 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

• Frequency:
  • Genomes: 𝑓 0.018 (89 hom., cov: 33)
  • Exomes 𝑓: 0.0012 (0 hom.)
• Consequence: SLC1A3 NM_004172.5 3_prime_UTR
• Clinical Significance: Benign criteria provided, single submitter B:1
• Conservation: PhyloP100: 1.83
• Publications: 3 publications found

Genes affected

SLC1A3 (HGNC:10941): (solute carrier family 1 member 3) This gene encodes a member of a member of a high affinity glutamate transporter family. This gene functions in the termination of excitatory neurotransmission in central nervous system. Mutations are associated with episodic ataxia, Type 6. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2014]

SLC1A3-AS1 (HGNC:56374): (SLC1A3 antisense RNA 1)

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.28).
• BP6: Variant 5-36686863-G-A is Benign according to our data. Variant chr5-36686863-G-A is described in ClinVar as Benign. ClinVar VariationId is 353338.Status of the report is criteria_provided_single_submitter, 1 stars.
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0623 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
SLC1A3	NM_004172.5	c.*594G>A		3_prime_UTR_variant	Exon 10 of 10	ENST00000265113.9	NP_004163.3

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
SLC1A3	ENST00000265113.9	c.*594G>A		3_prime_UTR_variant	Exon 10 of 10	1	NM_004172.5	ENSP00000265113.4

Frequencies

GnomAD3 genomes AF: 0.0184 AC: 2791 AN: 152048 Hom.: 89 Cov.: 33

Gnomad AFR AF: 0.0644

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.00603

Gnomad ASJ AF: 0.00

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.00

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.00316

Gnomad NFE AF: 0.000206

Gnomad OTH AF: 0.00956

GnomAD4 exome AF: 0.00119 AC: 15 AN: 12568 Hom.: 0 Cov.: 0 AF XY: 0.00101 AC XY: 7 AN XY: 6904

African (AFR) AF: 0.0313 AC: 2 AN: 64

American (AMR) AF: 0.00649 AC: 10 AN: 1540

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 114

East Asian (EAS) AF: 0.00 AC: 0 AN: 474

South Asian (SAS) AF: 0.00 AC: 0 AN: 1476

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 296

Middle Eastern (MID) AF: 0.0625 AC: 1 AN: 16

European-Non Finnish (NFE) AF: 0.00 AC: 0 AN: 8064

Other (OTH) AF: 0.00382 AC: 2 AN: 524

GnomAD4 genome AF: 0.0184 AC: 2795 AN: 152166 Hom.: 89 Cov.: 33 AF XY: 0.0180 AC XY: 1337 AN XY: 74400

African (AFR) AF: 0.0643 AC: 2668 AN: 41496

American (AMR) AF: 0.00602 AC: 92 AN: 15276

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 3472

East Asian (EAS) AF: 0.00 AC: 0 AN: 5172

South Asian (SAS) AF: 0.00 AC: 0 AN: 4822

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 10598

Middle Eastern (MID) AF: 0.00340 AC: 1 AN: 294

European-Non Finnish (NFE) AF: 0.000206 AC: 14 AN: 68012

Other (OTH) AF: 0.00946 AC: 20 AN: 2114

Alfa AF: 0.00353 Hom.: 2

Bravo AF: 0.0208

Asia WGS AF: 0.00346 AC: 12 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:1

Revision: criteria provided, single submitter

Submissions by phenotype

Episodic ataxia type 6 Benign:1

Jan 13, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.28
CADD	Benign	11
DANN	Benign	0.85
PhyloP100		1.8
Mutation Taster		=100/0	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs10428531; hg19: chr5-36686965;